Actively Recruiting
Microstructure Imaging in Stroke Patients
Led by Danish Research Centre for Magnetic Resonance · Updated on 2022-05-26
90
Participants Needed
2
Research Sites
479 weeks
Total Duration
On this page
Sponsors
D
Danish Research Centre for Magnetic Resonance
Lead Sponsor
B
Bispebjerg Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to establish a methodological framework based on existing advanced neuroimaging technologies as a new clinical neuroimaging tool for assessment of possible affected brain connections in stroke and TIA patients. Thus, providing new insights into microstructural changes that may underline why those patients experience deficits like fatigue.
CONDITIONS
Official Title
Microstructure Imaging in Stroke Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with stroke or transient ischemic attack (TIA) with ABCD2 score greater than 4 and/or an acute Diffusion-Weighted Image (DWI) lesion
- Modified Rankin Scale score of 2 or less
- Ability to comply with all study requirements as determined by the investigator
- Ability to understand and sign the informed consent form
- Score of 12 or higher on the Multidimensional Fatigue Inventory for general fatigue
- Healthy individuals age- and sex-matched to patient groups (for control group)
- Ability to comply with all study requirements and understand and sign the informed consent form (for controls)
You will not qualify if you...
- General MRI research exclusion criteria defined by DRCMR
- Pregnancy or breastfeeding; urine hCG test offered for women under 55 years
- Major medical illnesses such as anemia, diabetes mellitus, thyroid disorders, cardiovascular disease, or electrolyte imbalance
- Treatment with ritalin or modafinil
- Known uncontrolled severe malignancy
- Known drug or alcohol addiction
- Fatigue caused by pharmaceutical side effects as identified by the investigator
- Body weight over 130 kilograms
- Persons unwilling to be informed about abnormal findings from study investigations
- Recent infection within the last 3 weeks (for healthy controls only)
- Known malignancy (for healthy controls only)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Bispebjerg Hospital
Copenhagen, København NV, Denmark, 2400
Actively Recruiting
2
Danish Research Centre for Magnetic Resonance
Copenhagen, Denmark, 2650
Actively Recruiting
Research Team
M
Maria del Carmen Moreno Genis, MSc
CONTACT
T
Tim Bjørn Dyrby, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here